XML 40 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
FAIR VALUE MEASUREMENTS (Tables)
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
SCHEDULE OF FINANCIAL INSTRUMENT MEASURED ON RECURRING BASIS

   As of March 31, 2024   Fair Value Measurements 
       Fair   As of March 31, 2024 
   Amount   Value   Level 1   Level 2   Level 3 
                     
Liabilities:                         
Contingent consideration:                         
Asuragen (1)  $248   $248   $-   $-   $248 
Note payable:                         
BroadOak loan   9,400    8,841    -    -    8,841 
   $9,648   $9,089   $-   $-   $9,089 

 

(1) See Note 9, Other Accrued Expenses

 

   As of December 31, 2023   Fair Value Measurements 
   Carrying   Fair   As of December 31, 2023 
   Amount   Value   Level 1   Level 2   Level 3 
Liabilities:                    
Contingent consideration:                         
Asuragen (1)  $453   $453   $-   $-   $453 
Note payable:                         
BroadOak loan   10,000    9,343    -    -    9,343 
   $10,453   $9,796   $-   $-   $9,796 

 

(1) See Note 9, Other Accrued Expenses
SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION

A roll forward of the carrying value of the Contingent Consideration Liability and BroadOak loans to March 31, 2024 is as follows:

 

                   Adjustment     
   December 31,
2023
   Payments   Reversals   Accretion/
Interest
Accrued
   to Fair
Value/
Mark to
Market
   March 31,
2024
 
                         
Asuragen  $                453   $-   $(224)  $       19   $       -   $248 
                               
BroadOak loans   9,343    (600)   -    -    98    8,841 
                               
   $9,796   $(600)  $(224)  $19   $98   $9,089